FDA Establishes Advisory Committee for Digital Health Technology
The application deadline to serve on the committee is Dec. 11.
Troy Tazbaz, Director of Digital Health at Food & Drug Administration
The FDA announced in October the creation of a digital health advisory committee which will help the agency better understand the risks and benefits of emerging health care technology such as artificial intelligence and virtual reality.
“Technology moves at an incredible pace, and we’re excited to have a committee of experts throughout the field who can help ensure our regulation of these exciting tools maintains an appropriate pace while working within parameters of safety and effectiveness standards,” Troy Tazbaz, director of the FDA’s Digital Health Center of Excellence said in a news release.
The committee is expected to be fully operational in 2024. It will consist of nine voting members, including the chair. The agency seeks individuals with diverse scientific and technical experience.
The FDA is accepting applications until Dec. 11. The application can be found on the FDA Advisory Committee Membership Nomination Portal.
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
